Td Private Client Wealth LLC Abbott Laboratories Transaction History

Td Private Client Wealth LLC

$3.48 Trillion
Q3 2024

A detailed history of Td Private Client Wealth LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Td Private Client Wealth LLC holds 38,695 shares of ABT stock, worth $4.49 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

38,695

Previous 37,031 4.49%

Holding current value

$4.49 Million

Previous $3.85 Billion 14.65%

% of portfolio

0.13%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	BUY	$100.07 - $118.13 $166,516 - $196,568	1,664 Added 4.49%	38,695 $4.41 Billion
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $3.73 Million - $4.16 Million	37,031 New	37,031 $3.85 Billion
Q1 2024 Aug 16, 2024	BUY	$109.52 - $120.96 $198,012 - $218,695	1,808 Added 5.89%	32,507 $3.69 Billion
Q4 2023 Aug 16, 2024	BUY	$90.19 - $110.4 $208,609 - $255,355	2,313 Added 8.15%	30,699 $3.38 Billion
Q3 2023 Aug 16, 2024	BUY	$95.53 - $114.62 $38,403 - $46,077	402 Added 1.44%	28,386 $2.75 Billion
Q2 2023 Aug 16, 2024	SELL	$100.78 - $112.29 $2.45 Million - $2.73 Million	-24,300 Reduced 46.48%	27,984 $3.05 Billion
Q1 2023 Aug 16, 2024	BUY	$96.86 - $114.01 $660,972 - $778,004	6,824 Added 15.01%	52,284 $5.29 Billion
Q4 2022 Aug 16, 2024	SELL	$95.06 - $111.52 $2,376 - $2,788	-25 Reduced 0.05%	45,460 $4.99 Billion
Q3 2022 Aug 16, 2024	BUY	$96.76 - $112.03 $84,955 - $98,362	878 Added 1.97%	45,485 $4.4 Billion
Q2 2022 Aug 16, 2024	BUY	$102.07 - $123.37 $57,567 - $69,580	564 Added 1.28%	44,607 $4.85 Billion
Q1 2022 Aug 16, 2024	BUY	$114.02 - $139.04 $1.69 Million - $2.06 Million	14,832 Added 50.78%	44,043 $5.21 Billion
Q4 2021 Aug 16, 2024	SELL	$115.53 - $141.46 $92,192 - $112,885	-798 Reduced 2.66%	29,211 $4.11 Billion
Q3 2021 Aug 16, 2024	SELL	$116.66 - $129.06 $819,186 - $906,259	-7,022 Reduced 18.96%	30,009 $3.54 Billion
Q2 2021 Aug 16, 2024	SELL	$105.79 - $124.53 $1.34 Million - $1.57 Million	-12,627 Reduced 23.96%	40,070 $4.65 Billion
Q1 2021 Aug 16, 2024	BUY	$108.84 - $128.23 $608,524 - $716,933	5,591 Added 11.87%	52,697 $6.32 Billion
Q4 2020 Aug 16, 2024	BUY	$105.0 - $114.42 $1.07 Million - $1.16 Million	10,150 Added 27.47%	47,106 $5.16 Billion
Q3 2020 Aug 16, 2024	BUY	$91.64 - $111.29 $2.79 Million - $3.39 Million	30,438 Added 466.98%	36,956 $4.02 Billion
Q2 2020 Aug 16, 2024	BUY	$76.57 - $98.0 $25,804 - $33,026	337 Added 5.45%	6,518 $596 Million
Q1 2020 Aug 16, 2024	BUY	$62.82 - $91.86 $11,747 - $17,177	187 Added 3.12%	6,181 $488 Million
Q4 2019 Aug 16, 2024	SELL	$78.51 - $87.4 $2.44 Million - $2.71 Million	-31,037 Reduced 83.81%	5,994 $521 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Abbott Laboratories Transaction History